Article
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Clinical lymphoma, myeloma & leukemia - 1 May 2022
Polprasert Chantana, Niparuck Pimjai, Rattanathammethee Thanawat, Chuncharunee Suporn, Kobbuaklee Sirorat, Songserm Kritanan, Suksusut Amornchai, Trithiphen Sasinipa, Lanamtieng Theerin, Kongkiatkamon Sunisa, Chanswangphuwana Chantiya, Lawasut Panisinee, Bunworasate Udomsak, Rojnuckarin Ponlapat
Abstract excerpt
BACKGROUND: Unexplained cytopenia (UC) and low-risk myelodysplastic syndrome (MDS) are distinguished mainly by morphologic dysplasia, which sometimes shows inter-observer discrepancy. We hypothesized that gene mutations are strong prognostic factors for these low-risk patients. MATERIALS AND METHODS: We enrolled patients from 4 medical centers with unexplained cytopenia of at least 1 lineage. Diagnosis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.